CompletedPhase 4NCT00371878

Immunogenicity of 7-Valent Pneumococcal Conjugate Vaccine in Lung Fluid of Adults With and Without HIV Infection

Studying Pneumococcal meningitis

Last synced from ClinicalTrials.gov April 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Royal Liverpool University Hospital
Principal Investigator: Neil French, PhD FRCP
Karonga Prevention Study, London School of Tropical Medicine and Hygience
Intervention: 7-valent pneumococcal conjugate vaccine (Prevnar)(biological)
Enrollment: 40 target
Eligibility: 17 years · All sexes
Timeline: 2003 – 2003

Study locations (1)

Wellcome Trust Laboratories and Dept of Medicine, Queen Elizabeth Central Hospital, Blantyre, Malawi

Collaborators

Kamuzu University of Health Sciences · Liverpool School of Tropical Medicine · Wellcome Trust

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00371878 on ClinicalTrials.gov

Other trials for Pneumococcal meningitis

Additional recruiting or active studies for the same condition.

RECRUITINGNCT00901602
Lebanese Interhospital Pneumococcal Surveillance Program
American University of Beirut Medical Center

See all trials for Pneumococcal meningitis →

← Back to all trials